No Data
Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Might Be Weaker Than You Think
Scinai Immunotherapeutics Reports Financial Turnaround and Growth
12 Health Care Stocks Moving In Friday's Pre-Market Session
Scinai Immunotherapeutics 3Q Rev $168,000 >SCNI
Press Release: Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up From Negative $7.3 Million as of June 30, 2024, to Positive $10 Million
Scinai Leadership to Showcase Company's CGMP Biologics CDMO and Innovative I&I Pipeline During BIO-Europe 2024
No Data
No Data
MooMamaLlama : been riding novonix for cpl yrs, their synthetic graphite was going to attract attention, but adding an anode division to their cathode materials and battery tech was a smart move
70965684 : How much is the price? Thank you.
Jaguar8 OP 70965684 : Of what???
70965684 : Arqq
Jaguar8 OP 70965684 : Nah ARQQ is down 13.70
View more comments...